Janney Montgomery Scott LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$375
+76.9%
11,862
+128.3%
0.00%0.0%
Q2 2023$212
+6.0%
5,196
-3.3%
0.00%0.0%
Q1 2023$200
-100.0%
5,371
-57.7%
0.00%
-66.7%
Q3 2022$710,000
+13.8%
12,691
+5.9%
0.00%0.0%
Q2 2022$624,000
-31.5%
11,987
-4.3%
0.00%
-25.0%
Q1 2022$911,000
-36.9%
12,530
+2.6%
0.00%
-33.3%
Q4 2021$1,444,000
+23.6%
12,212
+40.3%
0.01%
+20.0%
Q3 2021$1,168,000
-21.2%
8,703
-4.9%
0.01%
-28.6%
Q2 2021$1,482,000
+87.4%
9,154
-7.1%
0.01%
+75.0%
Q1 2021$791,000
+70.8%
9,856
+15.8%
0.00%
+100.0%
Q4 2020$463,000
-12.1%
8,514
-73.5%
0.00%
-50.0%
Q2 2019$527,000
-0.4%
32,185
+3.9%
0.00%0.0%
Q1 2019$529,000
+33.6%
30,983
+6.7%
0.00%0.0%
Q4 2018$396,000
-52.3%
29,047
-0.0%
0.00%
-42.9%
Q3 2018$831,000
-1.3%
29,048
-5.6%
0.01%
-12.5%
Q2 2018$842,000
+28.7%
30,773
-0.8%
0.01%
+14.3%
Q1 2018$654,000
+1.7%
31,011
-7.3%
0.01%0.0%
Q4 2017$643,00033,4530.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders